Relmada Therapeutics' REL-1017 — Potential to Treat Reactive Tinnitus?

Discussion in 'Support' started by AxEars, Jul 11, 2022.

    1. AxEars

      AxEars Member

      Tinnitus Since:
      05/2022
      Cause of Tinnitus:
      Unknown
      https://www.relmada.com/product-development

      REL-1017 is in Phase 3 trials now. It is focusing on brain hyperexcitability. We all know that's a major factor in tinnitus.

      This drug doesn't belong in the Research News forum since it has no focus on tinnitus, but for those with reactive tinnitus, this might be another treatment.

      REL-1017's goal is to promote BDNF and block the NMDAR channel. This seems very promising for Major Depressive Disorder, but the neuronal actions seem related to our condition.
       
      • Like Like x 4
    2. Sam Marksmen
      Confused

      Sam Marksmen Member

      Tinnitus Since:
      06/2021
      Cause of Tinnitus:
      Meds
      My ENT said my auditory nerve was over excited, maybe this could be it.
       
Loading...
Similar Threads - Relmada Therapeutics' REL
  1. beeeep
    Replies:
    53
    Views:
    8,178

Share This Page